TSW
AGN

Thompson Siegel & Walmsley’s Allergan Inc AGN Stock Holding History

Thompson Siegel & Walmsley’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,710
Closed -$576K – 754
2014
Q4 		$576K Sell
2,710
-2,770
-51% -$551K 0.01% 319
2014
Q3 		$976K Sell
5,480
-1,010
-16% -$168K 0.02% 276
2014
Q2 		$1.1M Sell
6,490
-2,325
-26% -$362K 0.02% 276
2014
Q1 		$1.09M Buy
8,815
+4,800
+120% +$584K 0.02% 272
2013
Q4 		$446K Hold
4,015
– – 0.01% 337
2013
Q3 		$363K Sell
4,015
-43
-1% -$3.86K 0.01% 350
2013
Q2 		$342K Buy
+4,058
New +$421K 0.01% 365

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Thompson Siegel & Walmsley's AGN Position: Q1 2015 in Review

Thompson Siegel & Walmsley sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,710 shares — an estimated $576K sold.

Thompson Siegel & Walmsley first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.1M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Thompson Siegel & Walmsley reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 2,710 Allergan Inc shares in Q1 2015, an estimated $576K.
  • Thompson Siegel & Walmsley first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Thompson Siegel & Walmsley's Allergan Inc position peaked at $1.1M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2015, filed 13 May 2015.